See also our related blogs for the Keller Laboratory and the Pediatric Preclinical Testing Initiative.

Thursday, October 14, 2010

Strategic Plan

Our goals in the first 5 years are:
to successful partner basic science laboratories with the OHSU Pediatric Oncology Phase I Clinical Trial Program in order to develop 4 or more effective, molecularly targeted therapies,
to recruit 2 additional basic science laboratories in the areas of brain tumor (glioma) and neuroblastoma biology,
to  develop a $100M endowment as a key element to the second phase of recruitment and program building.

No comments:

Post a Comment